Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michalis Kontos

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Clinical Drug Investigation|May 11, 2018
Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II StudyEkaterini C Tampaki, Athanasios Tampakis, Constantinos E Alifieris, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 20, 2018
Health-related quality of life of young women with breast cancer. Review of the literatureAris Yfantis, George Intas, Maria Tolia, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Microwave versus saline-linked radiofrequency (Aquamantys) assisted liver resection in a porcine liver resection model. A safety and feasibility pilot studyDimitrios Kaparelos, Demetrios Moris, Michalis Kontos, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|July 16, 2011
A Malignant Gastrointestinal Stromal Tumor of the Gallbladder Immunoreactive for PDGFRA and Negative for CD 117 Antigen (c-KIT)Athanasios Petrou, Pari Alexandrou, Alexandros Papalambros, et al.
BMC Surgery|September 22, 2020
How breast cancer treatments affect the quality of life of women with non-metastatic breast cancer one year after surgical treatment: a cross-sectional study in GreeceAris Yfantis, Pavlos Sarafis, Ioannis Moisoglou, et al.
Journal of Cancer Research and Clinical Oncology|February 27, 2019
Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancerAristomenis Anestis, Panagiotis Sarantis, Stamatios Theocharis, et al.
Breast Cancer Research and Treatment|September 8, 2023
Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA studySteffi Hartmann, Maggie Banys-Paluchowski, Elmar Stickeler, et al.
The Lancet Regional Health. Europe|October 10, 2024
Axillary clearance and chemotherapy rates in ER+HER2- breast cancer: secondary analysis of the SENOMAC trialTove Filtenborg Tvedskov, Robert Szulkin, Sara Alkner, et al.
The British Journal of Surgery|June 29, 2022
Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST surveyMaria Luisa Gasparri, Jana de Boniface, Philip Poortmans, et al.
The Lancet. Oncology|August 9, 2024
Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trialJana de Boniface, Matilda Appelgren, Robert Szulkin, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Clinical Drug Investigation|May 11, 2018
Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II StudyEkaterini C Tampaki, Athanasios Tampakis, Constantinos E Alifieris, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 20, 2018
Health-related quality of life of young women with breast cancer. Review of the literatureAris Yfantis, George Intas, Maria Tolia, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Microwave versus saline-linked radiofrequency (Aquamantys) assisted liver resection in a porcine liver resection model. A safety and feasibility pilot studyDimitrios Kaparelos, Demetrios Moris, Michalis Kontos, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|July 16, 2011
A Malignant Gastrointestinal Stromal Tumor of the Gallbladder Immunoreactive for PDGFRA and Negative for CD 117 Antigen (c-KIT)Athanasios Petrou, Pari Alexandrou, Alexandros Papalambros, et al.
BMC Surgery|September 22, 2020
How breast cancer treatments affect the quality of life of women with non-metastatic breast cancer one year after surgical treatment: a cross-sectional study in GreeceAris Yfantis, Pavlos Sarafis, Ioannis Moisoglou, et al.
Journal of Cancer Research and Clinical Oncology|February 27, 2019
Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancerAristomenis Anestis, Panagiotis Sarantis, Stamatios Theocharis, et al.
Breast Cancer Research and Treatment|September 8, 2023
Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA studySteffi Hartmann, Maggie Banys-Paluchowski, Elmar Stickeler, et al.
The Lancet Regional Health. Europe|October 10, 2024
Axillary clearance and chemotherapy rates in ER+HER2- breast cancer: secondary analysis of the SENOMAC trialTove Filtenborg Tvedskov, Robert Szulkin, Sara Alkner, et al.
The British Journal of Surgery|June 29, 2022
Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST surveyMaria Luisa Gasparri, Jana de Boniface, Philip Poortmans, et al.
The Lancet. Oncology|August 9, 2024
Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trialJana de Boniface, Matilda Appelgren, Robert Szulkin, et al.
Pageof 4